Efficacy of lacosamide add-on therapy on Refractory Focal Epilepsies in children and adolescents: An open-label clinical trial

Efficacy of lacosamide add-on therapy on Refractory Focal Epilepsies in children and adolescents: An open-label clinical trial

Objective: Epilepsy is a chronic neurological disorder that affects 0.5%–1% of children. 30%–40% of patients are resistant to current anti-epileptic drugs. Lacosamide (LCM) appeared to be effective, safe, and well tolerated in children and adolescents. This study was aimed to evaluate whether LCM co...

Full description

Bibliographic Details
Main Authors: Tayebeh Mohammadi, Jafar Nasiri, Mohammad Reza Ghazavi, Omid Yaghini, Neda Hoseini
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Research in Pharmacy Practice
Subjects:
drug resistant epilepsy
lacosamide
partial epilepsy
pediatrics
Online Access:http://www.jrpp.net/article.asp?issn=2319-9644;year=2022;volume=11;issue=3;spage=109;epage=115;aulast=Mohammadi

Internet

http://www.jrpp.net/article.asp?issn=2319-9644;year=2022;volume=11;issue=3;spage=109;epage=115;aulast=Mohammadi

Similar Items